What is John B. Sanfilippo & Son's earnings per share (EPS)?

John B. Sanfilippo & Son (JBSS) reported diluted earnings per share of $5.26 for fiscal year 2026. This represents a 4.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

John B. Sanfilippo & Son Financials

JBSS

FY2026 annual

Revenue $1.2B +6.2% YoY

Net Income $61.9M +5.1% YoY

EPS (Diluted) $5.26 +4.6% YoY

Free Cash Flow $35.7M +277.3% YoY

Source SEC Filings (10-K/10-Q) Data as of Jun 25, 2026 Currency USD FYE June

John B. Sanfilippo & Son (JBSS) reported $1.2B in revenue for fiscal year 2026, up 6.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JBSS FY2026 2026-08-19

Revenue expansion is being absorbed by thinner margins and heavier reinvestment, making cash conversion the clearest operating signal.

Revenue reached $1.18B in FY2026, while operating income was only $89.2M; compared with its FY2021 base, that modest profit increase indicates that growth has not translated into much greater operating earnings. In FY2025, net income of $58.9M coexisted with negative free cash flow of -$20.2M, showing that accounting earnings were temporarily consumed by investment and working-capital needs.

Gross margin compressed from 21.6% in FY2021 to 18.0% in FY2026, so the business is carrying more sales without preserving its earlier unit economics. The pattern points to sustained cost or product-mix pressure rather than a one-year earnings interruption.

Capital intensity remained substantial: FY2026 capital spending of $88.1M consumed most operating cash flow, leaving $35.7M of free cash flow. Debt-to-equity rose from 0.0x in FY2021 to 0.1x in FY2026, indicating that expansion increasingly required additional balance-sheet funding even though leverage remains modest.

Financial Health Signals

Financial Health Score 62/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of John B. Sanfilippo & Son's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

John B. Sanfilippo & Son has an operating margin of 7.6%, meaning the company retains $8 of operating profit per $100 of revenue. This strong profitability earns a score of 73/100, reflecting efficient cost management and pricing power. This is unchanged from the prior year.

Growth

John B. Sanfilippo & Son's revenue grew 6.2% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 50/100.

Leverage

John B. Sanfilippo & Son carries a low D/E ratio of 0.11, meaning only $0.11 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 65/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

John B. Sanfilippo & Son's current ratio of 2.08 indicates adequate short-term liquidity, earning a score of 59/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

John B. Sanfilippo & Son has a free cash flow margin of 3.0%, earning a moderate score of 37/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

John B. Sanfilippo & Son earns a strong 16.3% return on equity (ROE), meaning it generates $16 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is unchanged from the prior year.

Altman Z-Score Safe

5.11

John B. Sanfilippo & Son scores 5.11, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/8

John B. Sanfilippo & Son passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.00x

For every $1 of reported earnings, John B. Sanfilippo & Son generates $2.00 in operating cash flow ($123.8M OCF vs $61.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

36.72x

John B. Sanfilippo & Son earns $36.72 in operating income for every $1 of interest expense ($89.2M vs $2.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY+6.2%

5Y CAGR+6.0%

10Y CAGR+4.2%

John B. Sanfilippo & Son generated $1.2B in revenue in fiscal year 2026. This represents an increase of 6.2% from the prior year.

EBITDA

$117.4M

YoY+5.2%

5Y CAGR+4.0%

10Y CAGR+6.4%

John B. Sanfilippo & Son's EBITDA was $117.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 5.2% from the prior year.

Net Income

$61.9M

YoY+5.1%

5Y CAGR+2.7%

10Y CAGR+8.9%

John B. Sanfilippo & Son reported $61.9M in net income in fiscal year 2026. This represents an increase of 5.1% from the prior year.

EPS (Diluted)

$5.26

YoY+4.6%

5Y CAGR+2.3%

10Y CAGR+8.3%

John B. Sanfilippo & Son earned $5.26 per diluted share (EPS) in fiscal year 2026. This represents an increase of 4.6% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$35.7M

YoY+277.3%

5Y CAGR-6.0%

10Y CAGR+33.3%

John B. Sanfilippo & Son generated $35.7M in free cash flow in fiscal year 2026, representing cash available after capex. This represents an increase of 277.3% from the prior year.

Cash & Debt

$1.1M

YoY+96.1%

5Y CAGR-5.7%

10Y CAGR-4.8%

John B. Sanfilippo & Son held $1.1M in cash against $43.6M in long-term debt as of fiscal year 2026.

Dividends Per Share

$4.00

YoY+90.5%

5Y CAGR-7.8%

10Y CAGR+10.3%

John B. Sanfilippo & Son paid $4.00 per share in dividends in fiscal year 2026. This represents an increase of 90.5% from the prior year.

Shares Outstanding

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin

18.0%

YoY-0.4pp

5Y CAGR-2.0pp

10Y CAGR+2.2pp

John B. Sanfilippo & Son's gross margin was 18.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is down 0.4 percentage points from the prior year.

Operating Margin

7.6%

YoY-0.1pp

5Y CAGR-1.3pp

10Y CAGR+1.5pp

John B. Sanfilippo & Son's operating margin was 7.6% in fiscal year 2026, reflecting core business profitability. This is down 0.1 percentage points from the prior year.

Net Margin

5.3%

YoY-0.1pp

5Y CAGR-0.9pp

10Y CAGR+1.9pp

John B. Sanfilippo & Son's net profit margin was 5.3% in fiscal year 2026, showing the share of revenue converted to profit. This is down 0.1 percentage points from the prior year.

Return on Equity

16.3%

YoY0.0pp

5Y CAGR-6.4pp

10Y CAGR+4.7pp

John B. Sanfilippo & Son's ROE was 16.3% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. That is unchanged from the prior year.

Capital Allocation

R&D Spending

$3.3M

YoY-4.6%

5Y CAGR+27.3%

10Y CAGR+14.2%

John B. Sanfilippo & Son invested $3.3M in research and development in fiscal year 2026. This represents a decrease of 4.6% from the prior year.

Capital Expenditures

$88.1M

YoY+73.7%

5Y CAGR+42.4%

10Y CAGR+24.4%

John B. Sanfilippo & Son invested $88.1M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 73.7% from the prior year.

Share Buybacks

Not reported for fiscal year 2026.

JBSS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JBSS annual income statement

Metric	FY26	FY25	FY24	FY23	FY21	FY20	FY19	FY18	FY17	FY15	FY14	FY13	FY12	FY10
Revenue	$1.2B+6.2%	$1.1B+3.8%	$1.1B+6.7%	$999.7M	$858.5M-2.5%	$880.1M+0.4%	$876.2M-1.4%	$888.9M+5.0%	$846.6M	$887.2M+14.0%	$778.6M+6.0%	$734.3M+4.8%	$700.6M	$561.6M
Cost of Revenue	$964.5M+6.7%	$903.8M+6.0%	$852.6M+8.2%	$788.1M	$673.5M-4.4%	$704.3M-1.9%	$717.9M-4.3%	$750.0M+6.4%	$704.7M	$755.2M+15.2%	$655.8M+6.7%	$614.4M+3.5%	$593.5M	$466.8M
Gross Profit	$211.2M+3.8%	$203.5M-5.0%	$214.1M+1.2%	$211.6M	$185.0M+5.2%	$175.8M+11.1%	$158.3M+13.9%	$138.9M-2.1%	$141.9M	$132.1M+7.5%	$122.9M+2.4%	$120.0M+12.1%	$107.1M	$94.8M
R&D Expenses	$3.3M-4.6%	$3.5M-3.5%	$3.6M+7.7%	$3.4M	$2.0M+100.2%	$999K+12.0%	$892K+27.2%	$701K+6.5%	$658K	$979K+11.0%	$882K-28.5%	$1.2M+16.1%	$1.1M	$927K
SG&A Expenses	$43.0M+8.1%	$39.8M-17.9%	$48.5M+8.7%	$44.6M	$36.8M-3.0%	$37.9M-0.2%	$38.0M+27.5%	$29.8M-7.1%	$32.1M	$30.5M+4.4%	$29.3M-6.3%	$31.2M+7.7%	$29.0M	$24.6M
Operating Income	$89.2M+5.3%	$84.7M-0.6%	$85.2M-5.6%	$90.2M	$85.2M+8.4%	$78.5M+34.2%	$58.5M+4.2%	$56.2M-7.1%	$60.5M	$51.9M+10.4%	$47.0M+12.9%	$41.6M+26.2%	$33.0M	$29.7M
Interest Expense	$2.4M-31.6%	$3.6M+39.3%	$2.5M+18.1%	$2.2M	$1.4M-28.1%	$2.0M-34.5%	$3.1M-11.6%	$3.5M+19.0%	$2.9M	$4.0M-8.9%	$4.4M-8.4%	$4.8M-11.4%	$5.4M	-$5.7M
Income Tax	$21.0M+11.1%	$18.9M-3.8%	$19.7M-12.5%	$22.5M	$20.1M+7.9%	$18.6M+43.5%	$13.0M-23.1%	$16.9M-6.5%	$18.0M	$15.6M+14.9%	$13.5M+0.1%	$13.5M+48.8%	$9.1M	$8.4M
Net Income	$61.9M+5.1%	$58.9M-2.2%	$60.2M-4.1%	$62.9M	$59.7M+10.4%	$54.1M+37.1%	$39.5M+21.4%	$32.5M-10.0%	$36.1M	$29.3M+11.5%	$26.3M+20.8%	$21.8M+27.1%	$17.1M	$14.4M
EPS (Diluted)	$5.26+4.6%	$5.03-2.3%	$5.15-4.6%	$5.40	$5.17+10.2%	$4.69+36.7%	$3.43+20.8%	$2.84-10.4%	$3.17	$2.61+10.6%	$2.36+19.2%	$1.98+25.3%	$1.58	$1.34

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Revenue	$280.4M-0.5%	$281.8M-10.5%	$314.8M+5.4%	$298.7M+11.0%	$269.1M+3.1%	$260.9M-13.3%	$301.1M+9.0%	$276.2M
Cost of Revenue	$236.3M+3.6%	$228.0M-10.8%	$255.6M+4.5%	$244.6M+11.0%	$220.3M+7.5%	$205.0M-17.6%	$248.8M+8.3%	$229.7M
Gross Profit	$44.1M-17.9%	$53.8M-9.1%	$59.2M+9.4%	$54.1M+10.9%	$48.8M-12.7%	$55.9M+7.0%	$52.3M+12.3%	$46.5M
SG&A Expenses	$11.1M+3.2%	$10.7M-11.0%	$12.1M+31.0%	$9.2M-14.8%	$10.8M+19.1%	$9.1M-11.7%	$10.3M+5.8%	$9.7M
Operating Income	$12.4M-47.8%	$23.8M-8.4%	$26.0M-3.9%	$27.0M+34.2%	$20.1M-28.6%	$28.2M+45.6%	$19.4M+13.9%	$17.0M
Interest Expense	$419K-19.9%	$523K+4.0%	$503K-48.9%	$984K-18.6%	$1.2M+14.6%	$1.1M+36.7%	$772K+49.6%	$516K
Income Tax	$2.7M-50.5%	$5.4M-16.8%	$6.6M+3.3%	$6.3M+38.2%	$4.6M-23.4%	$6.0M+39.5%	$4.3M+5.8%	$4.1M
Net Income	$8.4M-50.1%	$16.8M-6.2%	$18.0M-4.1%	$18.7M+38.4%	$13.5M-32.9%	$20.2M+48.2%	$13.6M+16.6%	$11.7M
EPS (Diluted)	N/A	$1.43-6.5%	$1.53-3.8%	$1.59	N/A	$1.72+48.3%	$1.16+16.0%	$1.00

No annual filing on record for: FY2011, FY2016, FY2022.

JBSS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JBSS annual balance sheet

Metric	FY26	FY25	FY24	FY23	FY21	FY20	FY19	FY18	FY17	FY15	FY14	FY13	FY12	FY10
Total Assets	$658.6M+10.2%	$597.6M+15.9%	$515.6M+21.2%	$425.3M	$398.5M-2.2%	$407.5M+4.1%	$391.3M-5.9%	$415.9M+4.5%	$398.1M	$431.9M+9.5%	$394.6M+5.3%	$374.7M+0.8%	$371.7M	N/A
Current Assets	$349.3M+0.8%	$346.4M+17.8%	$294.1M+15.6%	$254.4M	$225.2M-5.7%	$238.9M+6.0%	$225.3M-9.1%	$247.9M-2.2%	$253.4M	$284.3M+14.0%	$249.4M+11.4%	$223.8M+8.2%	$206.8M	N/A
Cash & Equivalents	$1.1M+96.1%	$585K+20.9%	$484K-75.2%	$1.9M	$672K-56.2%	$1.5M-3.5%	$1.6M+9.8%	$1.4M-25.9%	$2.0M	$1.9M+3.3%	$1.9M+125.9%	$834K-66.1%	$2.5M	$1.4M
Inventory	$245.8M-3.4%	$254.6M+29.5%	$196.6M+13.7%	$172.9M	$148.0M-14.0%	$172.1M+9.6%	$157.0M-9.9%	$174.4M-4.4%	$182.4M	$198.0M+8.3%	$182.8M+15.2%	$158.7M+8.4%	$146.4M	N/A
Accounts Receivable	$84.3M+10.0%	$76.7M-9.8%	$85.0M+16.8%	$72.7M	$66.3M+16.5%	$57.0M-6.6%	$61.0M-6.8%	$65.4M+0.9%	$64.8M	$75.6M+35.5%	$55.8M+12.7%	$49.5M-0.7%	$49.9M	N/A
Goodwill	$11.8M0.0%	$11.8M0.0%	$11.8M0.0%	$11.8M	$9.7M0.0%	$9.7M0.0%	$9.7M0.0%	$9.7M	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$278.6M+17.6%	$236.9M+22.8%	$193.0M+45.0%	$133.1M	$156.0M-7.8%	$169.2M+23.7%	$136.7M-20.9%	$172.9M+6.3%	$162.6M	$190.7M+13.6%	$167.8M+5.2%	$159.4M-6.6%	$170.7M	N/A
Current Liabilities	$167.9M+7.6%	$156.0M+23.9%	$125.9M+47.0%	$85.7M	$100.2M-10.7%	$112.2M+33.7%	$83.9M-28.4%	$117.2M+6.7%	$109.9M	$134.1M+19.5%	$112.2M+3.2%	$108.8M-9.1%	$119.7M	N/A
Long-Term Debt	$43.6M+199.1%	$14.6M+128.8%	$6.4M-10.4%	$7.1M	$10.9M-26.3%	$14.7M-27.7%	$20.4M-25.5%	$27.4M+8.5%	$25.2M	$32.3M-9.5%	$35.7M+5.9%	$33.7M-7.0%	$36.2M	N/A
Total Equity	$379.9M+5.3%	$360.7M+11.8%	$322.6M+10.4%	$292.2M	$242.5M+1.8%	$238.2M-6.4%	$254.6M+4.8%	$243.0M+3.2%	$235.5M	$241.3M+6.4%	$226.8M+5.4%	$215.3M+7.1%	$201.0M	$179.9M
Retained Earnings	$236.7M+6.9%	$221.5M+18.5%	$187.0M+15.8%	$161.5M	$126.3M+1.8%	$124.1M-9.9%	$137.7M+8.2%	$127.3M+3.4%	$123.2M	$135.7M+10.2%	$123.1M+8.5%	$113.4M+10.6%	$102.6M	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Total Assets	$658.6M+1.2%	$650.7M+5.3%	$617.7M+3.2%	$598.7M+0.2%	$597.6M+1.3%	$590.0M+8.2%	$545.3M+5.0%	$519.4M
Current Assets	$349.3M-0.8%	$352.1M+4.4%	$337.2M+1.1%	$333.5M-3.7%	$346.4M-0.8%	$349.2M+13.9%	$306.7M+6.7%	$287.5M
Cash & Equivalents	$1.1M-11.2%	$1.3M-46.2%	$2.4M+236.1%	$714K+22.1%	$585K-54.8%	$1.3M+285.4%	$336K-24.0%	$442K
Inventory	$245.8M-2.7%	$252.6M+7.3%	$235.4M+0.3%	$234.7M-7.8%	$254.6M-1.2%	$257.8M+25.2%	$205.8M+5.8%	$194.6M
Accounts Receivable	$84.3M-1.1%	$85.2M+6.8%	$79.8M-5.4%	$84.4M+10.1%	$76.7M+2.8%	$74.5M-8.2%	$81.2M-3.1%	$83.8M
Goodwill	$11.8M0.0%	$11.8M0.0%	$11.8M0.0%	$11.8M0.0%	$11.8M0.0%	$11.8M0.0%	$11.8M0.0%	$11.8M
Total Liabilities	$278.6M+5.9%	$263.0M+6.2%	$247.6M+5.0%	$235.9M-0.4%	$236.9M-2.7%	$243.4M+10.8%	$219.6M+5.3%	$208.6M
Current Liabilities	$167.9M+9.6%	$153.2M+3.2%	$148.4M+8.6%	$136.7M-12.4%	$156.0M-10.3%	$174.0M+15.9%	$150.1M+7.3%	$139.8M
Long-Term Debt	$43.6M+7.1%	$40.7M+41.0%	$28.8M-3.3%	$29.8M+104.8%	$14.6M+152.6%	$5.8M-3.4%	$6.0M-3.2%	$6.2M
Total Equity	$379.9M-2.0%	$387.6M+4.7%	$370.1M+2.0%	$362.8M+0.6%	$360.7M+4.1%	$346.6M+6.4%	$325.6M+4.8%	$310.8M
Retained Earnings	$236.7M-3.7%	$245.8M+7.4%	$229.0M+2.8%	$222.7M+0.6%	$221.5M+6.5%	$208.0M+10.7%	$187.8M+7.8%	$174.2M

No annual filing on record for: FY2011, FY2016, FY2022.

JBSS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

JBSS annual cash flow statement

Metric	FY26	FY25	FY24	FY23	FY21	FY20	FY19	FY18	FY17	FY15	FY14	FY13	FY12	FY10
Operating Cash Flow	$123.8M+305.4%	$30.5M-70.0%	$101.7M-18.4%	$124.7M	$104.7M+64.6%	$63.6M-23.8%	$83.5M+26.2%	$66.2M+25.6%	$52.7M	$13.9M+16.6%	$11.9M-66.6%	$35.8M+124.8%	$15.9M	$42.1M
Capital Expenditures	$88.1M+73.7%	$50.7M+79.1%	$28.3M+36.6%	$20.7M	$25.2M+67.6%	$15.0M-0.4%	$15.1M+14.0%	$13.2M+21.5%	$10.9M	$14.4M+45.0%	$9.9M+37.8%	$7.2M-4.3%	$7.5M	$8.5M
Free Cash Flow	$35.7M+277.3%	-$20.2M-127.5%	$73.4M-29.4%	$103.9M	$79.5M+63.7%	$48.6M-28.9%	$68.4M+29.2%	$52.9M+26.7%	$41.8M	-$459K-122.7%	$2.0M-92.9%	$28.5M+240.9%	$8.4M	$33.6M
Investing Cash Flow	-$86.2M-69.6%	-$50.8M+41.8%	-$87.3M-259.7%	-$24.3M	-$22.9M-63.4%	-$14.0M+3.9%	-$14.6M+58.2%	-$35.0M-231.7%	-$10.5M	N/A	N/A	-$6.4M+11.2%	-$7.2M	-$41.2M
Financing Cash Flow	-$37.1M-282.1%	$20.4M+229.1%	-$15.8M+84.0%	-$98.8M	-$82.6M-66.5%	-$49.6M+27.8%	-$68.7M-116.8%	-$31.7M+25.2%	-$42.4M	N/A	N/A	-$31.0M-308.9%	-$7.6M	-$243K
Dividends Paid	$46.8M+91.6%	$24.4M-29.9%	$34.8M-36.7%	$54.9M	$57.5M-16.4%	$68.7M+136.4%	$29.1M+2.5%	$28.4M-49.8%	$56.5M	$16.8M+1.0%	$16.6M+52.4%	$10.9M	N/A	N/A

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Operating Cash Flow	$29.0M+14628.4%	$197K-99.7%	$62.5M+94.5%	$32.1M-12.0%	$36.5M+241.0%	-$25.9M-335.9%	$11.0M+22.9%	$8.9M
Capital Expenditures	$19.1M-11.8%	$21.7M-3.5%	$22.4M-9.8%	$24.9M+84.5%	$13.5M+15.5%	$11.7M-14.4%	$13.6M+14.7%	$11.9M
Free Cash Flow	$9.9M+146.2%	-$21.5M-153.6%	$40.0M+451.9%	$7.3M-68.5%	$23.0M+161.3%	-$37.6M-1309.6%	-$2.7M+10.1%	-$3.0M
Investing Cash Flow	-$18.7M+11.9%	-$21.2M+0.5%	-$21.3M+14.5%	-$24.9M-85.0%	-$13.5M-15.0%	-$11.7M+14.2%	-$13.7M-14.3%	-$12.0M
Financing Cash Flow	-$10.5M-152.6%	$19.9M+150.4%	-$39.5M-458.3%	-$7.1M+70.2%	-$23.8M-161.6%	$38.6M+1399.0%	$2.6M-13.6%	$3.0M
Dividends Paid	$17.6M+50.1%	$11.7M	$0-100.0%	$17.5M	$0	$0	$0-100.0%	$24.4M

Not reported in any period shown, so not listed: Share Buybacks.

No annual filing on record for: FY2011, FY2016, FY2022.

JBSS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

JBSS annual financial ratios

Metric	FY26	FY25	FY24	FY23	FY21	FY20	FY19	FY18	FY17	FY15	FY14	FY13	FY12	FY10
Gross Margin	18.0%-0.4pp	18.4%-1.7pp	20.1%-1.1pp	21.2%	21.6%+1.6pp	20.0%+1.9pp	18.1%+2.4pp	15.6%-1.1pp	16.8%	14.9%-0.9pp	15.8%-0.6pp	16.3%+1.1pp	15.3%	16.9%
Operating Margin	7.6%-0.1pp	7.6%-0.3pp	8.0%-1.0pp	9.0%	9.9%+1.0pp	8.9%+2.2pp	6.7%+0.4pp	6.3%-0.8pp	7.1%	5.9%-0.2pp	6.0%+0.4pp	5.7%+1.0pp	4.7%	5.3%
Net Margin	5.3%-0.1pp	5.3%-0.3pp	5.7%-0.6pp	6.3%	7.0%+0.8pp	6.2%+1.7pp	4.5%+0.8pp	3.7%-0.6pp	4.3%	3.3%-0.1pp	3.4%+0.4pp	3.0%+0.5pp	2.4%	2.6%
Return on Equity	16.3%0.0pp	16.3%-2.3pp	18.7%-2.8pp	21.5%	24.6%+1.9pp	22.7%+7.2pp	15.5%+2.1pp	13.4%-2.0pp	15.3%	12.2%+0.6pp	11.6%+1.5pp	10.1%+1.6pp	8.5%	8.0%
Return on Assets	9.4%-0.5pp	9.9%-1.8pp	11.7%-3.1pp	14.8%	15.0%+1.7pp	13.3%+3.2pp	10.1%+2.3pp	7.8%-1.3pp	9.1%	6.8%+0.1pp	6.7%+0.9pp	5.8%+1.2pp	4.6%	N/A
Current Ratio	2.08-0.1x	2.22-0.1x	2.34-0.6x	2.97	2.25+0.1x	2.13-0.6x	2.69+0.6x	2.12-0.2x	2.31	2.12-0.1x	2.22+0.2x	2.06+0.3x	1.73	N/A
Debt-to-Equity	0.11+0.1x	0.040.0x	0.020.0x	0.02	0.040.0x	0.060.0x	0.080.0x	0.110.0x	0.11	0.130.0x	0.160.0x	0.160.0x	0.18	N/A
FCF Margin	3.0%+4.9pp	-1.8%-8.7pp	6.9%-3.5pp	10.4%	9.3%+3.7pp	5.5%-2.3pp	7.8%+1.9pp	5.9%+1.0pp	4.9%	-0.1%-0.3pp	0.3%-3.6pp	3.9%+2.7pp	1.2%	6.0%

Metric	Q4'26	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25
Gross Margin	15.7%-3.3pp	19.1%+0.3pp	18.8%+0.7pp	18.1%0.0pp	18.1%-3.3pp	21.4%+4.1pp	17.4%+0.5pp	16.9%
Operating Margin	4.4%-4.0pp	8.4%+0.2pp	8.3%-0.8pp	9.0%+1.6pp	7.5%-3.3pp	10.8%+4.4pp	6.4%+0.3pp	6.2%
Net Margin	3.0%-3.0pp	6.0%+0.3pp	5.7%-0.6pp	6.3%+1.2pp	5.0%-2.7pp	7.7%+3.2pp	4.5%+0.3pp	4.2%
Return on Equity	2.2%-2.1pp	4.3%-0.5pp	4.9%-0.3pp	5.2%+1.4pp	3.8%-2.1pp	5.8%+1.6pp	4.2%+0.4pp	3.8%
Return on Assets	1.3%-1.3pp	2.6%-0.3pp	2.9%-0.2pp	3.1%+0.9pp	2.3%-1.2pp	3.4%+0.9pp	2.5%+0.2pp	2.2%
Current Ratio	2.08-0.2x	2.300.0x	2.27-0.2x	2.44+0.2x	2.22+0.2x	2.010.0x	2.040.0x	2.06
Debt-to-Equity	0.110.0x	0.100.0x	0.080.0x	0.080.0x	0.040.0x	0.020.0x	0.020.0x	0.02
FCF Margin	3.5%+11.2pp	-7.6%-20.3pp	12.7%+10.3pp	2.4%-6.1pp	8.6%+23.0pp	-14.4%-13.5pp	-0.9%+0.2pp	-1.1%

No annual filing on record for: FY2011, FY2016, FY2022.

Similar Companies

Seneca Foods Corp SENEB

$1.3B

Seneca Foods Corp SENEA

$1.3B

Treehouse Foods THS

$1.2B

Utz Brands Inc UTZ

$1.3B

Herbalife HLF

$1.3B

Where John B. Sanfilippo & Son Ranks

Frequently Asked Questions

What is John B. Sanfilippo & Son's annual revenue?

John B. Sanfilippo & Son (JBSS) reported $1.2B in total revenue for fiscal year 2026. This represents a 6.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is John B. Sanfilippo & Son's revenue growing?

John B. Sanfilippo & Son (JBSS) revenue grew by 6.2% year-over-year, from $1.1B to $1.2B in fiscal year 2026.

Is John B. Sanfilippo & Son profitable?

Yes, John B. Sanfilippo & Son (JBSS) reported a net income of $61.9M in fiscal year 2026, with a net profit margin of 5.3%.

What is John B. Sanfilippo & Son's EBITDA?

John B. Sanfilippo & Son (JBSS) had EBITDA of $117.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does John B. Sanfilippo & Son have?

As of fiscal year 2026, John B. Sanfilippo & Son (JBSS) had $1.1M in cash and equivalents against $43.6M in long-term debt.

What is John B. Sanfilippo & Son's gross margin?

John B. Sanfilippo & Son (JBSS) had a gross margin of 18.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

What is John B. Sanfilippo & Son's operating margin?

John B. Sanfilippo & Son (JBSS) had an operating margin of 7.6% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

What is John B. Sanfilippo & Son's net profit margin?

John B. Sanfilippo & Son (JBSS) had a net profit margin of 5.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Does John B. Sanfilippo & Son pay dividends?

Yes, John B. Sanfilippo & Son (JBSS) paid $4.00 per share in dividends during fiscal year 2026.

What is John B. Sanfilippo & Son's return on equity (ROE)?

John B. Sanfilippo & Son (JBSS) has a return on equity of 16.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

What is John B. Sanfilippo & Son's free cash flow?

John B. Sanfilippo & Son (JBSS) generated $35.7M in free cash flow during fiscal year 2026. This represents a 277.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is John B. Sanfilippo & Son's operating cash flow?

John B. Sanfilippo & Son (JBSS) generated $123.8M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

What are John B. Sanfilippo & Son's total assets?

John B. Sanfilippo & Son (JBSS) had $658.6M in total assets as of fiscal year 2026, including both current and long-term assets.

What are John B. Sanfilippo & Son's capital expenditures?

John B. Sanfilippo & Son (JBSS) invested $88.1M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

How much does John B. Sanfilippo & Son spend on research and development?

John B. Sanfilippo & Son (JBSS) invested $3.3M in research and development during fiscal year 2026.

What is John B. Sanfilippo & Son's current ratio?

John B. Sanfilippo & Son (JBSS) had a current ratio of 2.08 as of fiscal year 2026, which is generally considered healthy.

What is John B. Sanfilippo & Son's debt-to-equity ratio?

John B. Sanfilippo & Son (JBSS) had a debt-to-equity ratio of 0.11 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is John B. Sanfilippo & Son's return on assets (ROA)?

John B. Sanfilippo & Son (JBSS) had a return on assets of 9.4% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

What is John B. Sanfilippo & Son's Altman Z-Score?

John B. Sanfilippo & Son (JBSS) has an Altman Z-Score of 5.11, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is John B. Sanfilippo & Son's Piotroski F-Score?

John B. Sanfilippo & Son (JBSS) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are John B. Sanfilippo & Son's earnings high quality?

John B. Sanfilippo & Son (JBSS) has an earnings quality ratio of 2.00x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can John B. Sanfilippo & Son cover its interest payments?

John B. Sanfilippo & Son (JBSS) has an interest coverage ratio of 36.72x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is John B. Sanfilippo & Son?

John B. Sanfilippo & Son (JBSS) scores 62 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.